AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2015
May 7, 2015
29821_dirs_2015-05-07_e2bcdc92-fd8c-4434-b07a-b0648f083a62.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2015-05-05
Reporting Person: LUDWIG EDWARD J (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-05-05 | Deferred Stock Units | $ | A | 5325.0000 | Acquired | Common Stock (5325.0000) | Direct | |
| 2015-05-05 | Stock Option (Right to Buy) | $17.3700 | A | 16818.0000 | Acquired | 2025-05-05 | Common Stock (16818.0000) | Direct |
Footnotes
F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2: Reflects a value of $92,500 divided by the closing price of common stock on the date of grant.
F3: Reporting person elected to receive half of the annual equity award of $185,000 in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan.
F4: Reporting person elected to receive half of the annual equity award of $185,000 in the form of an option to purchase a specified number of shares of common stock vesting in full upon the next annual meeting of stockholders.